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Acute Arthritis Complicating Rubella Vaccination 
George R. Thompson, Alfredo Ferreyra and Robert G. Brackett 
After a field trial of rubella virus vaccine (HPV-77 DK 12 strain), 329 children 
(2.8%) developed joint symptoms. Forty had complete rheumatologic evaluation 
and constitute the basis of this report. Twenty children (50%) had predominantly 
knee complaints; 13 (33%) had symptoms suggesting the carpal tunnel syn- 
drome; and 7 (17%) had polyarthritis. The mean duration of arthritis was 18.4 
days, and the mean interval between vaccination and onset of arthritis was 
30.6 days. 
Rubella is considered the leading cause 
of congenital malformations and fetal 
death in the United States. Gregg’s original 
observations (l), in 1941, relating congeni- 
tal cataracts and other abnormalities to 
maternal rubella, have been amply 
confirmed. The  incidence of fetal abnor- 
malities after maternal rubella in the first 
trimester of pregnancy has been estimated 
at 7 to 70qib by prospective studies (2) and 
as high as 100% by retrospective studies 
The consequences, to the fetus, of mater- 
nal rubella include spontaneous abortion 
(3)- 
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and stillbirth, deafness, heart disease, cat- 
aract, glaucoma, and psychomotor retarda- 
tion. In the neonatal period, a frequent, 
and often severe, complication is throm- 
bocytopenic purpura. Aside from the hu- 
manitarian aspects, the cost of the total 
program to treat and provide special edu- 
cation for children damaged by the 1964 
epidemic in New York alone has been 
estimated at 2.2 billion dollars (4). Thus, 
there has been great interest in the de- 
velopment of a program for the prevention 
of congenital rubella. This has become a 
reality with the isolation of the rubella 
virus in 1961 (5,6) and the subsequent 
development of an attenuated strain for 
vaccination (7,s). 
Arthritis is a frequent complication of 
naturally occurring rubella, particularly in 
adults, but also, occasionally, in children 
(9-11). Rubella virus has been recovered 
from the synovial fluid of a 1-year-old child 
(12). Arthritis has been observed frequent- 
ly in adults after vaccination with HPV-77, 
Candehill, and RA 27/23 strains (13-18). In 
one series of 35 adult women, 15 developed 
arthritis or arthralgias, and rubella virus 
was isolated from synovial fluid in one case 
(15). Arthritis has also been observed in 
children after vaccination (13,19), but the 
incidence is much less frequent. 
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After a large field trial of rubella vaccine 
in schoolchildren, we had the opportunity 
to carefully study 40 children who de- 
veloped arthritis. Our observations on 
these children constitute the basis of this 
report. 
MATERIALS AND METHODS 
In the Spring of 1969, a large field trial of live 
rubella virus vaccine was conducted in Southeastern 
Michigan.* The  vaccine used was the HPV-77 
strain, additionally passaged 12 times in dog kidney 
cell cu1tures.t Previous studies had indicated that 
this vaccine was highly immunogenic, inducing high 
antibody titers (20). 
A total of 11,758 school children were vaccinated. 
On the basis of rubella hemagglutination-inhibition 
(HI) antibody titers (21) , 6172 children, or 52.5% 
were susceptible, no rubella antibody or a titer less 
than 1:4 had been demonstrated in serum samples 
obtained prior to vaccination. Similarly, 4485 chil- 
dren were immune: rubella antibody was present 
prior to vaccination. Prevaccination specimens were 
not obtained from 1101 children. A seroconversion 
rate of 99% was obtained based on the development 
of an HI antibody titer of 1:16 of greater. 
Careful follow-up was conducted by means of a 
30-day parental reporting form and a telephone 
reporting system which was maintained throughout 
the entire study. Three hundred and twenty-nine 
vaccinees, or 2.8’%, were reported to have joint 
complaints. Of these 329, 80.7y0 were in the 
susceptible group, and 17.90/, were immune. If 
classified by their prevaccination immunologic 
status, 251 (4.1%) of the susceptible children were 
reported to have experienced arthritis or arthral- 
gias, as did 59 (1.3%) of the immune children, and 
19 (1.7%) of those whose serologic status was not 
determined. Further, those in the immune group 
had much milder symptoms, experiencing arthral- 
gias and not arthritis, with only one child judged to 
have mild arthritis. 
Based on this follow-up system, 49 of the 329, or 
0.4’%, were classified as having arthritis, the remain- 
der had arthralgias. 
Subsequently 40 of the children with more severe 
symptoms were referred to us for complete evalua- 
tion of their joint complaints. This  included a 
*This study was conducted by Parke, Davis and 
+Produced hy Phillips Roxane, Inc, St. Joseph, 
Company. 
Missouri. 
careful history and a complete physical examina- 
tion, with particular attention to the musculo- 
skeletal system. Blood was obtained for a complete 
blood count, Wintrobe sedimentation rate, serum 
protein electrophoresis, and rubella HI antibody 
titers. Also done were a battery of serologic studies, 
including the Veneral Disease Research Laboratory 
(VDRL) test, C-reactive protein, latex test for 
rheumatoid factor, a fluorescent test for antinuclear 
antibody using human leukocytes as substrate and 
antistreptolysin-0 antibody titers. 
Complete follow-up of these 40 children was done 
by telephone conversation with one of the parents 
hy the authors approximately six weeks after initial 
examination. Further follow-up information was 
obtained by mailed questionnaire or by telephone 
five mouths later. Some of the children also had 
second examinations. 
RESULTS 
The age distribution of these children is 
depicted in Fig 1. The  age range was from 
4 to 12 years, with a median age of 7 years 
and mean age of 7.6 years. This is the same 
;IS the mean age of the susceptible group 
for the whole study population. Twenty- 
one were female and 19 male. There were 
four sets of siblings. The  interval between 
vaccination and onset of articular symp- 
toms ranged from 14 to 55 days, with a 
mean of 30.6 days. Table 1 gives the 
distribution of patients over this time span, 
Age Range : 4-12 Years 
Median Age : 7 Years 
“1 
4 5 6  
;li 7 8  
21 - FEMALE 
19- MALE 
kge in Years 
Fig 1. Age distribution of the 40 children studied. 
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Table 1. Interval Between Vaccination and 
Onset of Arthritis 






















from which the mean value was obtained. 
For the purposes of this study, arthritis 
was defined as either joint pain or stiffness 
on motion. Arthralgias were defined as 
only mild articular aching without func- 
tional impairment. By these criteria, 37 of 
the 40 children had arthritis and 3 had 
only arthralgias. 
The  joints involved are listed in Fig 2. 
The  knee was the most commonly involved 
joint, producing symptoms in  26 children 
(5 of whom, however, had only arthralgias 
of the knee). T h e  next most frequently 
involved joint was the wrist, occurring in 
20 patients. T h e  metacarpophalangeal and 
interphalangeal joints were involved in 7 
each, the elbow in 5, ankle in  2, and hip in 
2 patients. Tenosynovitis, as manifest by 
swelling of the dorsum of the hand, was 
present in 5 children. Definite joint 
effusion was observed in none of the 40 
children examined. 
T h e  duration of symptoms in these 40 
children ranged from 1 to 46 days, with 
mean of 18.4 days. All joint symptoms 
cleared without residual impairment. How- 
ever, on follow-up contact, it was found 
that 2 patients had had monthly recurrence 
of knee pain, with limping and inability to 
fully extend the knee, typical of their early 
symptoms. This would last two or three 
days and clear, only to recur the next 
month. This persisted thru the fourth 
month after vaccination, but has not subse- 
quently recurred. Another patient had in- 
termittent arthralgias thru the fourth 
month. Three other children were reported 
to have recurrence of some musculoskeletal 
complaints, all of which were mild, and 
dissimilar to their earlier, acute symptoms. 
It is of interest that 2 of these 3 were the 
only children in  the study who had a past 
history of articular complaints. 
Three patterns of symptoms were ob- 
served to occur in these children. T h e  
patterns could be characterized as predomi- 
nantly knee complaints, which occurred in 
20 (50%) cases; symptoms suggestive of 
carpal tunnel syndrome occurred in 13 
(33%) and polyarticular complaints oc- 
curred in 7 (17%) of the cases. 
T h e  knee symptoms usually consisted of 
stiffness, with pain on motion and inability 
to fully extend the leg because of pain in 
the knee. The  knee was the only joint 
involved in 15 patients, and in 5 of these 
the involvement was monarticular. Three 
others experienced only arthralgias in addi- 
tion to their knee arthritis. T h e  remaining 
2 patients had, in addition, involvement of 
the wrist in  1 and the elbow in the other. 
Of the 20 patients with knee complaints, 
half were male and half were female. T h e  
average duration of knee symptoms was 
17.5 days. However, i f  one excludes 3 pa- 
tients who had symptoms for 45, 43, and 35 
days respectively, the mean duration of 
symptoms for the remaining 17 patients 
was only 7.4 days, with a range of 4-34 
days. Knee problems also tended to be 
recurrent and, as noted above, the 2 pa- 
tients with monthly recurrence of joint 
complaints both had knee symptoms. An 
example of this symptom complex is illus- 
trated in the following case: 
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*Knee - 26 (5 arthralgias only) 
*Wrist - 20 
*MCP - 7 
*PIPrrIP - 7 
"Elbow - 5 
*Ankle - 2 (1 arthralgias only) 
*Hip - 2 (1 arthralgias only) 
iiTenosynovitis" - 5 
Fig 2. Joints involved in the 40 children studied. 
SC, an 8-year-old boy, received his rubella vaccine 
on April 18, 1969. Approximately one week later he 
developed coryza with intermittent low grade fever. 
These symptoms persisted for three weeks. For two 
days on May 28 and 29, 1969, his mother noticed 
an erythematous macular skin eruption on his 
chest, abdomen and back. On June 9, 1969, 52 days 
post vaccination, he awoke with pain and stiffness 
in  his right knee. No swelling, redness, or warmth 
was noted, and after he was rip and about, it 
improved markedly. However, these symptoms 
gradually became worse, with stiffness lasting into 
the day: by June 15 he was unable to straighten the 
right knee and required crutches for ambulation. 
His parents felt there was minimal swelling and 
increased warmth in  the knee. He had no other 
joint symptoms. 
He was seen a t  Wayne County General Hospital 
on  June 18, 1969. A t  that time, the examination was 
all normal exept for the right knee, which ap- 
peared slightly swollen, measured '/4 inch larger in 
circumference than the left, and was warm and 
tender to palpation. No definite effusion was 
present. Motion of the knee was painful and lacked 
20" of full extension. 
Laboratory studies revealed a hemoglobin concen- 
tration of 14.0 g/100 ml, a white blood cell count of 
7200/cu mm and a Wintrobe sedimentation rate of 6 
inm/hr. Serologic studies were all negative. Anti- 
streptolysin-0 titer was 12 Todd units. Serum pro- 
tein electrophoresis showed 6.7 g/100 ml total 
protein with 4.29 g albumin (64y0), 0.34 g ~1,  
globulin ( 5 7 3 ,  0.60 g a2 (9%), 0.71 p (11%) : and 
0.75 g y globulin (11%). T h e  rubella H I  antibody 
titer. which was negative before vaccination, was 
13256 a t  the time of examination. 
T h e  patient was treated with aspirin and local 
heat to the knee and his symptoms gradually 
cleared completely 21 days after onset. He has hatl 
no recurrence. 
The  most annoying group of symptoms 
were those simulating tlie carpal tunnel 
syndrome. Characteristically, the child 
would awaken at night with pain, nunib- 
ness, and tingling sensations in the wrist 
and hand, often traveling u p  the forearm 
to the elbow. This would usually keep the 
child awake and crying most of the night. 
T h e  symptoms cleared with activity during 
the day, only to recur at night waking the 
child from sleep. These symptoms occurred 
in 13 (33%) oE the 40 children and in- 
cluded 7 boys and 6 girls. T h e  average 
cliil.ation oE symptoms was 18.6 days with a 
range of 344 days. If one excludes tlie 
patient whose symptoms lasted 44 days and 
were less marked than those in others, the 
average duration for the remaining 12 was 
16.5 days, with a range of 3-25 days. Nerve 
conduction studies were done on 2 of these 
patients at  the time of their examination, 
and hoth were normal. The  following case 
report illustrates this problem: 
RG an 8-year-old boy, received his rubella vac- 
cination on May 1, 1969. He was well until 26 days 
post vaccination, when he awoke with pain in the 
left knee. T h e  pain cleared by the time he hatl 
finished breakfast, and he had no further difficulty 
until June 1, 1969, when he developed pain and 
aching in the right wrist, metacarpophalangeal and 
proximal interphalangeal joints of the right hand 
associated with a tingling sensation, as if his hand 
were "asleep". T h e  paresthesias often extended up 
his arin toward the .elbow. Characteristically, the 
symptoms would occur a t  night, awaken him from 
sleep and keep him awake most of the night. On 
one occasion he was taken to a hospital emergency 
unit at  4:OO AM for help. However, in the morning 
his symptoms would clear and he did not miss 
school. 
He was seen a t  Wayne County General Hospital 
on June 12, 19G9. Examination disclosctl a healthy 
appearing boy. Physical findings were within nor- 
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mal limits. except for a questionably positi\e 
Tinel’s sign on the right and some tenderness to 
palpation of the left third metacarpophalangeal 
joint. and the right hip. 
Laboratory studies showed a hematocrit of 38%, 
a white blood cell count of 8200 cells/cu mm and a 
sedimentation rate (Wintrobe) of 5 mm/hr. 
Routine serologic studies were negative. Antistrep- 
tolysin-0 titer was 166 Todd units. Serum protein 
electrophoresis showed a total protein of 6.1 g/100 
nil, with 3.87 g albumin (59.5%), 0.39 g a1 globulin 
(5.9%) 0.62 g (9.5%), 0.73 g p (11.3%). and 
0.89 g y-globulin (13.7%). Nerve conduction veloci- 
ties were measured in both the right and left upper 
extremities and were all within normal limits. 
Rubella HI antibody titer was negative before 
vaccination and 1:128 at the time of examination at 
Wayne County General Hospital. 
He was started on aspirin therapy on June 11; 
ant1 symptoms gradually improved, completely 
clearing within 21 days after onset. He has had no 
recurrence. 
The symptom-complex least commonly 
seen could be classified as polyarthritis. 
This occurred in 7 (17y0) of cases. Five 
were females and 2 males. T h e  duration of 
these symptoms ranged from one to 46 
days, with a mean of 20.4 days. Both large 
and small joints were involved, and morn- 
ing stiffness was a frequent complaint. A 
typical case is described below: 
K N ,  a 10-year-old girl, received her rubella 
vaccination on May 6, 1969. On May 19, 1969 she 
developed a sore throat and burning of the eyes, 
but no fever or other symptoms. Two days later, 
she noticed an erythematous macular skin eruption 
on her upper thighs, which lasted until May 26. On 
May 25, for one day only, she had a generalized 
eruption over her entire body which was described 
as “hives”. She was then asymptomatic until 23 days 
post vaccination, when she developed aching in her 
joints. By June 2 this became worse with definite 
pain, tenderness and stiffness involving the knees, 
wrists, and subsequently the hands. Morning 
stiffness of one hour’s duration was present, but no 
night pain. 
She was seen at Wayne County General Hospital 
on June 10, 1969. The complete examination was 
normal except for the joints. There was tenderness 
and swelling of the right wrist, and possibly some 
effusion. The left wrist was normal. The left third 
metacarpophalangeal joint was tender and swollen 
as were the left first, third and fourth proximal 
interphalangeal joints. The grip on the left was 
weak. Tenosynovitis of the extensor tendon sheaths 
was thought present on the dorsum of the right 
wrist. Both knees were tender and painful to move, 
but .not swollen, and could be taken through a full 
range of motion. 
Laboratory studies showed a hemoglobin of 13.2 
g/100 ml; a white blood cell count of 8100, and 
a sedimentation rate (Wintrobe) of 12 mm/hr. 
Serologic studies were negative. Anti-streptolysin-0 
titer was 100 Todd units. Total serum proteins 
were 7.12 g/100 ml, with 429 g albumin (60%): 
0.40 g al globulin (5.7%) ; 0.44 g a2 (6.2%) ; 0.99 g 
0 (13.9%): and 0.99 g 7-globulin (13.9%). At the 
time of examination her rubella HI titer was 1:32 
(it was negative before vaccination) . 
She was treated with aspirin arid heat to the 
involved joints, and her symptoms gradually 
cleared, completely 19 days after onset. She has not 
had recurrence. 
I n  these 40 children, a history of coryza 
was elicited in 10, occurring some time 
between vaccination and the time of exam- 
ination. Similarly 9 children had experi- 
enced cough, and 8 a minor sore throat. 
Whether these symptoms were related to 
the rubella vaccination or to an  intercur- 
rent infection was impossible to ascertain. 
Eight children similarly were reported to 
have had a skin rash, though only one 
patient had a rash at the time of examina- 
tion. No correlation between the reported 
rash and arthritis was observed. Fever was 
described in 5 of the children, but no 
temperature over 100.5’ F, was observed at 
the time of the examination. Lym- 
phadenopathy was reported in 4 children 
at some time between vaccination and ex- 
amination. Similar data from the entire 
group of susceptable children vaccinated, 
computed from returned questionnaires, 
indicated fever in 11.5%; rash in 6%; and 
cervical lymphadenopathy in 5.6%. How- 
ever, rubella immune children were also 
reported to have fever in 8.7%; rash in 
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3.30/, and lymphadenopathy in 4%. In  
weighing these differences it must be taken 
into account that the immune were slightly 
older than the susceptibles. 
All of the 40 patients studied had nega- 
tive rubella HI antibody titers prior to 
vaccination (ie, were susceptible), and all 
developed significant antibody titers fol- 
lowing vaccination. At the time of exami- 
nation, the mean HI titer was 1:151.7, and 
the median titer was 1:128. The  range ol 
antibody titers was 1:32 to 1:512. Antibody 
titers in these patients when obtained at 
the routine bleeding 4-6 weeks post vac- 
cination were similar. This represents a 
very good antibody response and is not 
significantly different from that obtained 
for the total study population. 
Generally, the laboratory studies done 
were unremarkable. None of the patients 
were anemic, and white blood cell counts 
ranged from 5150-1 1,600 cells-cu mm, with 
only 5 over 10,000 cells/cu mm. The  battery 
of serologic tests included the VDRL test, 
C-reactive protein, latex slide test for rheu- 
matoid factor, and a fluorescent test for 
antinuclear antibodies. All were negative 
except for a positive test for antinuclear 
antibodies, a speckled pattern, occurring in 
an 11-year-old girl with polyarthritis. Aside 
from a protracted course (46 days), noth- 
ing was unusual about this girl, and all of 
the remainder of her laboratory studies 
were normal. She has remained well 
through the period of follow-up. 
Antistreptolysin-0 titers were generally 
negative or in low titer. One child had a 
titer of 1:500 (the highest observed); 2 had 
titers of 1:333, and 2 of 1:250. The  remain- 
der were all lower. These elevated A S 0  
titers were thought to represent intercur- 
rent streptococcal infection. Two of the 
highest titers observed (1 : 500 and 1 : 333) 
were in siblings. Clinically, these children 
did not differ from the others. 
The  Wintrobe erythrocyte sedimentation 
rate ranged from 3.5 to 21 mm/hr, with a 
mean of 9.6 mm/hr. Only 3 patients had 
sedimentation rates over 15 mm/hr. Serum 
protein electrophoresis was essentially nor- 
mal. The  only remarkable finding was 
some elevation of the a2 globulin over 0.8 
g/100 ml in 10 children. The  highest of 
these was 1.08 g/lOO ml. Eight of these 10 
children had knee complaints, and 2 had 
symptoms suggesting the carpal tunnel syn- 
drome. 
DISCUSSION 
It seems reasonable to consider the ar- 
thritis observed to be secondary to rubella 
vaccination. It would be most unusual to 
observe 40 new cases of juvenile rheuma- 
toid arthritis all within one month’s period 
of time. Also, the lack of elevation of the 
sedimentation rate, and the benign course 
with complete clearing without recurrence, 
are all against rheumatoid arthritis. Simi- 
larly, the benign course, absence of cardiac 
abnormalities, normal sedimentation rate 
and low serum antistreptolysin-0 titers are 
against rheumatic fever. Besides arthritis, 
other manifestations to support a diagnosis 
of serum sickness were absent. In  addition 
to rubella, other viruses may cause acute 
arthritis. However, this is rare, and there 
was little evidence to suggest another viral 
infection. Finally, it has been established 
that the HPV-77 rubella virus vaccine can 
produce arthritis in the adult, and the 
virus has been recovered from synovial 
fluid (15). Thus, we feel confident that the 
arthritis observed in these children was 
secondary to rubella virus vaccination. 
Comparison with the arthritis following 
naturally occurring rubella is interesting. In 
a series of 11 patients (9) the youngest of 
whom was 10 years and the mean age of 32 
years, the duration of arthritis ranged from 
3 to 28 days, with a mean of 9 days. The  
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arthritis occurred with the acute illness, and 
appeared no later than the sixth day after 
the rash. The  most common joints involved 
were the metacarpophalangeal; proximal 
interphalangeal, knee and wrist. One pa- 
tient had symptoms of the carpal tunnel 
syndrome, bilaterally. Tenosynovitis of the 
extensorpollicis longus tendon secondary to 
rubella has also been described (22). 
While arthritis after rubella vaccination 
is distressing, i t  appears to be a self-limited 
complication. All of the children eventual- 
ly cleared without residual, although in a 
very few i t  tended to be recurrent. Further 
continued surveillance of these children is 
planned. 
It is important to recognize that arthritis 
may occur nearly two months after vaccina- 
tion. Often the vaccination is forgotten, 
and the physician is not given this informa- 
tion unless he specifically inquires. By 
remembering that self-limited arthritis may 
occur after rubella vaccination, both the 
parents and physician may be spared a 
great deal of anxiety when faced with a 
child so afflicted. 
Aspirin in adequate doses usually afford- 
ed relief, as did local heat to the involved 
joint. In some cases mild sedation (such as 
elixir of diphenhydramine) proved help- 
ful. Short courses of adrenocorticosteroids 
have been used by others and reported of 
benefit (15). One of our patients received 
one 10 mg dose of prednisone from a 
relative with apparent improvement. How- 
ever, we feel aspirin is sufficient in most 
cases, and in view of the self-limited nature 
of the illness, therapy should be conserva- 
tive. 
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